Posted by Michael Wonder on 09 Oct 2020
New transparency measures for prescription medicines
9 October 2020 - The Australian Government has given approval to proceed with two measures to enhance transparency for prescription medicines.
The changes follow almost 18 months of consultations and are in response to public demand for more information on prescription medicines that are under evaluation by the TGA.
Presently, to the frustration of patients, carers and health practitioners, information on market authorisation approval of a prescription medicine only becomes publicly available with registration in the Australian Register of Therapeutic Goods (ARTG).
From January 2021, the TGA will publish a description of major innovator medicine applications that are under evaluation by the TGA. Information about the potential availability of new medicines, new uses for existing medicines and new combinations will be published on the TGA website.
